SCHEMBL5585355

SCHEMBL5585355

O=C1C(=Cc2ccc(O)cc2)CCC1=Cc1ccc(O)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 1.00
CYP2C9 P11712 2/20 1.00
CYP3A4 P08684 1/20 1.00
HSD11B1 P28845 3/20 0.85
F3 P13726 1/20 0.85
MGAM O43451 1/20 0.73
GAA P10253 1/20 0.73
SI P14410 1/20 0.73
MGAM2 Q2M2H8 1/20 0.73
MIF P14174 5/20 0.67
CYP26A1 O43174 2/20 0.67
EGFR P00533 1/20 0.59
F2 P00734 2/20 0.59
F10 P00742 2/20 0.59
KMT2A Q03164 1/20 0.59
ACHE P22303 1/20 0.55
PTGS2 P35354 1/20 0.55
MAPT P10636 1/20 0.55
HPGD P15428 1/20 0.55
HTT P42858 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5585354 1.00 CYP1A2 (1.00) CYP1A2CYP2C9CYP3A4HSD11B1F3
SCHEMBL14473242 1.00 CYP1A2 (1.00) CYP1A2CYP2C9CYP3A4HSD11B1F3
SCHEMBL5585181 0.92 CYP2C9 (1.00) CYP1A2CYP2C9CYP3A4HSD11B1F3
SCHEMBL14473217 0.92 CYP2C9 (1.00) CYP1A2CYP2C9CYP3A4HSD11B1F3
SCHEMBL5585182 0.92 CYP2C9 (1.00) CYP1A2CYP2C9CYP3A4HSD11B1F3
SCHEMBL1524816 0.87 CYP2C9 (0.76) CYP1A2CYP2C9CYP3A4HSD11B1F3
SCHEMBL1524814 0.87 CYP2C9 (0.76) CYP1A2CYP2C9CYP3A4HSD11B1F3
SCHEMBL17077374 0.82 EGFR (0.89) CYP1A2CYP2C9CYP3A4MIFCYP26A1
SCHEMBL17077373 0.82 EGFR (0.89) CYP1A2CYP2C9CYP3A4MIFCYP26A1
SCHEMBL608355 0.82 CYP2C9 (0.70) CYP1A2CYP2C9CYP3A4HSD11B1F3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12094507-B2 Hologram recording composition, hologram recording medium, diffraction optical element, and optical device, optical component, and image display device using diffraction optical element Sony Group Corporation (JP) 2024-09-17 US disclosed
EP-3896530-B1 HOLOGRAM RECORDING COMPOSITION, HOLOGRAM RECORDING MEDIUM, DIFFRACTION OPTICAL ELEMENT, AND OPTICAL DEVICE, OPTICAL COMPONENT, AND IMAGE DISPLAY DEVICE IN WHICH DIFFRACTION OPTICAL ELEMENT IS USED SONY GROUP CORP (JP) 2023-05-24 EP disclosed
CN-113168129-B Hologram recording composition, hologram recording medium, diffractive optical element, and optical device, optical member, and image display device using diffractive optical element 索尼集团公司 2022-08-05 CN disclosed
US-20220013142-A1 HOLOGRAM RECORDING COMPOSITION, HOLOGRAM RECORDING MEDIUM, DIFFRACTION OPTICAL ELEMENT, AND OPTICAL DEVICE, OPTICAL COMPONENT, AND IMAGE DISPLAY DEVICE USING DIFFRACTION OPTICAL ELEMENT Sony Group Corporation (JP) 2022-01-13 US disclosed
EP-3896530-A1 HOLOGRAM RECORDING COMPOSITION, HOLOGRAM RECORDING MEDIUM, DIFFRACTION OPTICAL ELEMENT, AND OPTICAL DEVICE, OPTICAL COMPONENT, AND IMAGE DISPLAY DEVICE IN WHICH DIFFRACTION OPTICAL ELEMENT IS USED Sony Group Corporation (JP) 2021-10-20 EP disclosed
WO-2020121653-A1 HOLOGRAM RECORDING COMPOSITION, HOLOGRAM RECORDING MEDIUM, DIFFRACTION OPTICAL ELEMENT, AND OPTICAL DEVICE, OPTICAL COMPONENT, AND IMAGE DISPLAY DEVICE IN WHICH DIFFRACTION OPTICAL ELEMENT IS USED ソニー株式会社 2020-06-18 WO disclosed
US-20170002019-A1 SYNTHESIS OF ISOHEXIDE ETHERS AND CARBONATES ARCHER DANIELS MIDLAND CO (US) 2017-01-05 US disclosed
EP-3083638-A1 SYNTHESIS OF ISOHEXIDE ETHERS AND CARBONATES Archer Daniels Midland Company (US) 2016-10-26 EP disclosed
CN-105873934-A SYNTHESIS OF ISOHEXIDE ETHERS AND CARBONATES 阿彻丹尼尔斯米德兰德公司 2016-08-17 CN disclosed
WO-2015094716-A1 SYNTHESIS OF ISOHEXIDE ETHERS AND CARBONATES ARCHER DANIELS MIDLAND COMPANY (US) 2015-06-25 WO disclosed
EP-1247797-B1 Cycloalkanone Derivates MERCK PATENT GMBH (DE) 2007-07-04 EP disclosed
US-6939479-B2 Cycloalkanone derivatives MERCK PATENT GMBH (DE) 2005-09-06 US disclosed
US-20030080321-A1 Cycloalkanone derivatives MERCK KGAA (DE) 2003-05-01 US disclosed
EP-1247797-A2 Cycloalkanone Derivates MERCK PATENT GmbH (DE) 2002-10-09 EP disclosed
US-6156866-A Chiral nematic polycarbonates BASF AKTIENGESELLSCHAFT (DE) 2000-12-05 US disclosed
WO-1995022586-A1 NEW POLYMERISABLE LIQUID CRYSTAL COMPOUNDS BASF AKTIENGESELLSCHAFT (DE) 1995-08-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170002019-A1 SYNTHESIS OF ISOHEXIDE ETHERS AND CARBONATES SI, GALE, ADH1C CYP1A2 2010/4885CYP2C9 576/4885CYP3A4 774/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.